Abstract
Introduction
Metabolic syndrome is complex disorder unifying dyslipidemia, insulin resistance and hyper insulinemia. Rising global epidemic of obesity has tremendous impact on metabolic syndrome. Ultrasound is becoming widely utilized modality for measuring the visceral adiposity.
Aim
To determine the usefulness of ultrasonographic measurements in the estimation of regional adiposity and to compare them with anthropometric measurements and to correlate ultrasonographic measurements of regional adiposity and metabolic syndrome.
Materials and Methods
A cross-sectional study was conducted to compare anthropometry and ultrasonography in assessing the regional adiposity in metabolic syndrome. A total of 105 consecutive participants were included in the study after scrutinizing them for various definable factors of metabolic syndrome. Body Mass Index (BMI) of all participants was calculated and their available serological investigations were gathered. Primarily participants were subjected for anthropometric measurements like waist circumference and hip circumference, further waist/hip ratio was calculated. Following which all participants underwent sonological examination and sonographic indices like intraabdominal fat thickness, preperitoneal fat thickness, minimum and maximum subcutaneous fat thicknesses were measured. Abdominal wall fat index was calculated as ratio of maximum preperitoneal fat thickness to minimum subcutaneous fat thickness. Statistical analysis was performed using SPSS (Statistical Package Social Science, version-10.0.5) software. A p-value was calculated and values <0.05 were considered as statistically significant.
Results
Significant correlation was established between the BMI and waist and hip circumferences. Mild positive correlation was obtained between BMI and sonographic indices like IAF, SCF and PPF with Pearson correlation (r) values of 0.324, 0.585 and 0.211 respectively. Anthropometric measurements showed higher r-values (WC- 0.624 and HC- 0.825) than sonographic indices; indicating anthropometry is better in assessing the regional adiposity than the sonography.
Conclusion
Sonography can be considered as one of the reliable imaging modality for assessing the regional adiposity but not as better as waist or hip circumferences.
Keywords: Central adiposity, Intra-abdominal fat thickness, Waist hip ratio
Introduction
Obesity has emerged as pandemic in both developed and developing countries [1]. Morbid obesity is affecting 5% of the Indian population [2]. Obesity is a risk factor for various diseases like diabetes mellitus, hypertension, stroke, hyperlipidemia, coronary artery disease, gallbladder disease, osteoarthritis, sleep apnea and several types of cancer. Intra abdominal fat is directly related to this cluster of metabolic risk factors termed as syndrome X or metabolic syndrome by Reaven [3].
The Metabolic Syndrome (MS) is a multiplex risk factor for atherosclerotic cardiovascular disease. It consists of an atherogenic dyslipidemia, elevation of blood pressure and glucose, prothrombotic and proinflammatory states. The MS promote the development of cardiovascular disease at multiple levels [4,5].
There is approximately two fold risk of developing Cardiovascular Diseases (CVD) and fivefold risk of developing diabetes mellitus in individuals with metabolic syndrome. Depending on the number of components of MS present in individuals, the probability of developing diabetes and/or CVD within 20 years ranges between 30%–40% [6]. In South Asia 20%–25% of individuals have developed MS and many more may be prone to it [7,8]. Compared with other various distributions of adipose tissue in body, regional adipose tissue deposition is most critical in defining and initiating the metabolic syndrome. The visceral adiposity is associated with higher plasma glucose, high plasma insulin, hyperlipidemia and decreased HDL cholesterol concentrations which are components of metabolic syndrome [9]. Apart from biochemical and serological investigations, researchers are springing up with various imaging modalities to quantify and qualify the abdominal obesity.
The current precise and gold standard investigation for estimating the intra abdominal fat is Computed Tomography (CT) or Magnetic Resonance Imaging (MRI); however both are limited by their cost, availability and radiation hazards [3]. It has been advocated that ultrasonography can estimate the regional adiposity accurately and is easily available, safe and cost-effective [3].
This study was conducted to measure the regional adiposity of each patient suffering from metabolic syndrome by ultrasonography and correlating these measurements with biochemical factors, anthropometric measurements and body mass indices.
Materials and Methods
This was a cross-sectional study conducted in the department of radiodiagnosis and imaging KVG Medical College and Hospital Sullia, Karnataka, India, in subjects diagnosed with metabolic syndrome. Study was conducted from May 2013 to May 2015. Only patients with metabolic syndrome with age more than thirty years were included in the study whereas participants with no metabolic syndrome irrespective of body mass index and those who underwent recent abdominal surgery and liposuction were excluded from the study.
The study was approved by the Institutional Ethical Committee. All the subjects were informed about the study in their local language and written consent was taken from them.
After taking appropriate clinical history and recording blood pressure, height, weight and BMI of the patients, their Random Blood Sugar (RBS) values were obtained. Patients were diagnosed to have metabolic syndrome using the new International Diabetes Federation (IDF) criteria, which defines metabolic syndrome as a condition involving any three of the following parameters; regional obesity (measured in current study with BMI of more than 25 kg/mm2), raised triglycerides (>200 mg/dl), reduced HDL cholesterol (<35mg/dl), raised blood pressure (systolic> 140 mmHg or diastolic> 90 mm Hg) and raised fasting plasma glucose (>125 mg/dl) [10].
So in the current study, the three parameters were used for diagnosing metabolic syndrome viz., regional obesity (BMI > 25Kg/mm2), raised blood pressure (systolic> 140 mmHg or diastolic > 90 mm Hg) and raised RBS (>200 mg/dl). Only patients clinically diagnosed to have metabolic syndrome were included in the study. The body mass index (BMI) was calculated as weight in kilograms/height in m2. Blood pressure (BP) was measured by cuff method using a sphygmomanometer after keeping participant in resting position for at least 10 minutes.
During the entire study period, 105 subjects were clinically diagnosed to have metabolic syndrome using the above criteria and they were made to go through further thorough anthropometric measurements.
The patients clothing was removed from the waist line and was made to stand with feet shoulder width apart and back straight. Waist circumference was measured halfway between the lower rib and the iliac crest with the bottom edge of the measuring tape aligned with the top of the iliac crest and parallel to the floor. Measurement was done in full expiration. Similarly, hip circumference was measured at the level of the greater trochanter. The waist hip ratio was calculated [11].
After recording anthropometric measurements trans-abdominal sonographies were performed with both curvilinear and linear transducers of GE Voluson 730 expert ultrasonographic machine. Patients were made to lie supine on ultrasound couch with relaxed abdomen and shoulders, heels, and buttocks in contact with the examination bed. Various sonographic indices were measured using either linear (7.5 MHz) or curvilinear probes (3.5 MHz) as follows [Table/Fig-1a,b, 2a-c, 3a-c].
Intra Abdominal Fat thickness (IAF): Measured with curvilinear probe in xiphoumbilical line mid way between xiphoid process and umbilicus. It is the distance between the anterior wall of the aorta and the posterior surface of the rectus abdominis muscle.
Preperitoneal Fat thickness (PPF): Measured in longitudinal plane with linear high frequency probe in the region of xiphoid process. It is the distance from the anterior surface of the liver to the posterior surface of the linea alba.
Minimum Subcutaneous fat thickness (SCFMIN): Measured in longitudinal plane with linear high frequency probe in the region of xiphoid process. It is the distance between the anterior surface of linea alba and the fat-skin barrier.
Maximum Subcutaneous fat thickness (SCFMAX): Measured in transverse plane with linear high frequency probe in the supra umbilical region. It is the distance between the anterior surface of linea alba and the fat-skin barrier.
Abdominal wall fat index (AFI): It is the ratio of maximum preperitoneal to minimum subcutaneous fat thickness [11].
Statistical Analysis
Statistical analysis were performed using SPSS (Statistical Package Social Science, version-10.0.5) software. Pearson correlation coefficients of anthropometry and sonographic indices with BMI were calculated which showed significant correlation at 0.05 level.
Results
In the current study 105 patients were diagnosed to have metabolic syndrome by selecting three of following five criteria; obesity, raised triglycerides, reduced HDL cholesterol, raised blood pressure and raised fasting plasma glucose. Among them 48 were females and 57 were males. Subjects were distributed depending on their BMI [Table/Fig-4]. The distribution of the patients based on their BMI and presence of diabetes mellitus is portrayed in [Table/Fig-5].
[Table/Fig-4]:
Sl. No. | BMI categorization | Frequency | |
---|---|---|---|
1 | < 18 | Under weight | 5 |
2 | 18-24.9 | Normal | 33 |
3 | 25-29.9 | Overweight | 37 |
4 | >30 | Obese | 30 |
The minimum age of the subject suffering from the metabolic syndrome was 31 years and maximum age of subject was 83 years. The mean age group in this study was 57.25 years with Standard Deviation (SD) of 11.23. Most of the metabolic syndrome cases in the present study were in the age group above sixth decade, followed by fourth and seventh decades.
According to one of the research conducted on Southern Indian population the cut off value of waist circumference for the diagnosis of central obesity in males is 85 cm and 80 cm in females [12]. With above reference values, 47 males and 44 females were categorized under central obesity. Same research work on Southern Indian population also provided the cut off value of waist hip ratio in males as 0.88 and in females as 0.81 [12]. With above reference values, 56 males and 47 females were categorized under central obesity.
Anthropometric measurements and sonographic indices were correlated with body mass index as standard. Pearson correlation coefficient was calculated at 2 tailed significance. The study showed positive correlation between BMI and waist/hip circumferences. Waist hip ratio showed poor correlation with BMI [Table/Fig-6]. Out of five sonographic indices AFI showed poor correlation with BMI. Intra-abdominal fat thickness, preperitoneal fat thickness, minimum and maximum subcutaneous fat thickness showed positive correlations with BMI [Table/Fig-7]. Minimum and maximum subcutaneous fat thicknesses showed much better correlation than others with r-value around 0.500. It was demonstrated that anthropometry is better for assessing the regional adiposity than sonographic indices. But indices like intra-abdominal fat, subcutaneous fat and preperitoneal fat thicknesses show higher association with BMI.
[Table/Fig-6]:
Parameters | BMI | WC | HC | WHR |
---|---|---|---|---|
Pearson correlation (r) | 1 | 0.624 (**) | 0.825 (**) | -0.115 |
Significant (2 tailed) | <0.001 | <0.001 | 0.254 | |
N | 105 | 105 | 105 | 105 |
Correlation is significant at 0.01 level.
BMI = Body Mass Index, WC = Waist Circumference, HC = Head Circumference, WHR = Waist Hip Ratio
[Table/Fig-7]:
Parameters | BMI | IAF | PPF | SCFMIN | SCFMAX | AFI |
---|---|---|---|---|---|---|
Pearson correlation (r) | 1 | 0.324** | 0.211* | 0.585** | 0.513** | -0.207 |
Significant (2 tailed) | 0.001 | 0.035 | <0.001 | <0.001 | 0.039 | |
N | 105 | 105 | 105 | 105 | 105 | 105 |
Correlation is significant at 0.05 level.
Correlation is significant at 0.01 level.
BMI= Body Mass Index, IAF = Intra abdominal fat thickness, PPF = Preperitoneal fat thickness, SCFMIN = Minimum Subcutaneous fat thickness, SCFMAX = Maximum Subcutaneous fat thickness, AFI = Abdominal wall fat index
Considering the waist circumference as reference value for diagnosing the regional adiposity, its values were correlated with few significant sonographic indices like intra-abdominal fat thickness, minimum subcutaneous fat thickness and maximum subcutaneous fat thickness, which showed mild positive correlation with p-value of less than 0.05. A total of 105 participants were categorized into predominantly visceral adiposity if AFI is more than one and subcutaneous adiposity if AFI is less than one. A total of 40 participants had AFI less than one and referred as predominant subcutaneous adiposity where as 65 had AFI more than one and are referred as predominant visceral adiposity.
[Table/Fig-8] demonstrates the correlation coefficient values of anthropometric and sonographic indices for metabolic syndrome with random blood sugar levels. None of the anthropometric measurements showed positive correlation with random blood sugar, one of the metabolic risk factors. Whereas IAF, SCF and PPF revealed mild but positive correlation with random blood sugar levels.
[Table/Fig-8]:
Parameters | RBS | IAF | PPF | SCFMIN | SCFMAX | AFI | Anthro pometry |
---|---|---|---|---|---|---|---|
Pearson correlation (r) | 1 | 0.0129 | 0.2015 | 0.0256 | 0.0444 | -0.1431 | -0.0272 |
Significant (2 tailed) | 0.900 | 0.047 | 0.802 | 0.664 | 0.160 | 0.0124 | |
N | 105 | 105 | 105 | 105 | 105 | 105 | 105 |
RBS = Random blood sugar, IAF = Intra abdominal fat thickness, PPF = Preperitoneal fat thickness, SCFMIN = Minimum Subcutaneous fat thickness, SCFMAX = Maximum Subcutaneous fat thickness, AFI = Abdominal wall fat index.
Discussion
This was a cross-sectional study performed on 105 consecutive individuals fitting into metabolic syndrome. Only 30 individuals in study were obese, 37 were overweight and remaining 38 were normal/under weight on BMI scale. However, they were included in the study as they had abnormal lipid profiles, diabetes mellitus and/or hypertension. Similar study was conducted by Kim SK et al., in Seoul, Korea where 32.65% were with normal BMI, 33.23% were overweight and 34.10% were obese [13]. They also included such individuals into the study as they were having abnormal lipid profiles, diabetes mellitus and/or hypertension. Hence, it is important to know that BMI is not the accurate judge of visceral adiposity, lean subjects categorized as normal or underweight may possess dreaded centrally located body fat which is responsible for catastrophe of metabolic syndrome [14].
Recently conducted study in Royapuram, Chennai, India, by Snehalatha C et al., gave cut off values for waist circumference as 85 cm and 80 cm for men and women respectively; correspondingly waist hip ratio of 0.88 and 0.81 respectively [12].
Following the same criteria we categorized our participants into centrally obese and non obese. By using above definition of waist circumference, 82.54% of males and 91.66% of females were classified as centrally obese. Waist hip ratio was still more significant and showed 98.24% of males and 97.9% of females as centrally obese in the current study.
Observing the [Table/Fig-9], it is clear that our study showed similar anthropometric results as that of studies conducted in Seoul [13], Taharan [15] and Netherland [16]. However, in the current study females had upper hand in waist circumference than males. In rest of the comparative studies males had more waist circumference than females. Waist hip ratios were almost similar in our study and in study conducted by Shabestari AA et al., [15].
[Table/Fig-9]:
Studies | Waist circumference | Waist hip ratio | ||
---|---|---|---|---|
Male | Female | Male | Female | |
Current study | 92.64 ±11.72 | 96.95± 17.7 | 0.98 ± 0.14 | 0.92 ± 0.09 |
Stolk RP et al., [16] | 93.9 ± 10.8 | 91.8± 9.5 | 0.91 ± 0.01 | 0.91 ± 0.01 |
Kim SR et al., [13] | 88 ± 7.8 | 84.2 ±11.2 | 0.93 ± 0.04 | 0.93 ± 0.07 |
Shabestari AA et al., [15] | 100 ±12.1 | 98 ±13.6 | 0.98 ± 0.05 | 0.90 ± .09 |
We correlated anthropometric measurements with BMI of participants. Waist circumference and hip circumference showed good correlation with BMI, with correlation coefficient values of 0.624 and 0.825 respectively. Waist hip ratio showed no correlation with BMI, with Pearson correlation coefficient of -0.115. Stolk RP et al., showed similar correlation with BMI and waist circumference with r-value of 0.824 [16]; whereas Shabestari AA et al., showed mild correlation with r-value of 0.285 [15]. Study conducted by Pouliot MC et al., concluded that waist circumference is much better anthropometric measurement than waist hip ratio and even better correlated with metabolic syndrome [17]. Authors also pronounced that waist circumference measured mid way between lower border of ribcage and iliac crest is more closely related with level of abdominal visceral adipose tissue than waist hip ratio in both sexes. Current study results almost marches on the same path of research conducted by Pouliot MC et al., and declares that waist circumference and hip circumference are better anthropometric indices for regional adiposity, where as waist hip ratio is poor indicator [17].
Next we compared and correlated various sonographic indices with BMI. Except for AFI rest four of sonographic indices showed positive correlation with BMI. SCFMAX and SCFMIN showed good correlation with BMI with correlation Coefficients of 0.513 and 0.585 respectively, followed by IAF with r-value of 0.324.
Maximum PPF depicted mild positive correlation with BMI with r-value of 0.211. Intra-abdominal fat thickness is considered as one of the most reliable sonographic index to measure visceral adiposity.
On sighting the [Table/Fig-10], it is clear that Kim et al., and Stolk et al., showed good correlation of IAF with BMI [13,16]. Current study gave comparable results as with researches conducted by Shabestari AA et al., Roopkala MS et al., and Shojaei MH et al., with r-value in the range of 0.32 to 0.46 [15,18,19].
[Table/Fig-10]:
On sighting the [Table/Fig-11] it was revealed that IAF compared and correlated with one of the metabolic risk factors (blood sugar levels), showed positive but mild correlation. In current study r-value was around 0.0129. Research conducted by other authors for the same showed r-values in the range of 0.1 to 0.3. So it can be concluded that IAF measured by sonography is better in estimating regional adiposity and shows mild positive correlation with metabolic risk factors.
[Table/Fig-11]:
Studies have shown good correlation between subcutaneous fat thickness and metabolic risk factors [20,21]. On scrutinizing the [Table/Fig-12] it is enlightening that subcutaneous fat thickness shows positive and good correlation with BMI in the current study. Studies done by Shabestari AA et al., and Roopkala MS et al., also show similar results [15,18]. Shojaei MH et al., showed very strong correlation between subcutaneous fat thickness and BMI with a value of 0.809 [19].
[Table/Fig-12]:
On correlating blood sugar levels with minimum and maximum subcutaneous fat thicknesses in current study showed mild positive correlation with correlation coefficient values of 0.0256 and 0.044 respectively. Study conducted by Shabestari AA et al., showed likewise results with r-value of 0.009 [15]; whereas, Seibert H et al., showed poor correlation. Preperitoneal fat thickness is one of the better sonographic indices in diabetics and lean patients [22]. In lean patients subcutaneous fat thickness will be small resulting in high abnormal AFI, giving erroneous results [3]. Kim SK et al., and Shabestari AA et al., also depicted likewise results with r-value of 0.33 and 0.344 respectively [13,15].
While assessing metabolic syndrome risk factors in current study, preperitoneal fat thickness showed mild positive correlation with blood sugar values; r-value being 0.2015. Study conducted by Kim SK et al., showed similar results with r-value of 0.11. Among all sonographic indices preperitoneal fat thickness showed better correlation in assessing metabolic syndrome [13]. Tayama K et al., showed elevated preperitoneal fat thickness is associated with severity of diabetes mellitus, increased cardiovascular disease risk factors and poor prognosis in these participants [23].
In the evaluation of regional adiposity AFI showed poor correlation with BMI in the present study with correlation coefficient value of -0.115. Similar results were also obtained by Kim SK et al., and Shabestari AA et al., [13,15].
When scrutinized for the role of AFI for evaluating metabolic risk factors like blood sugar levels in the current study, it showed poor correlation with r-value of – 0.1431. In comparison studies performed by Kim SK and Shabestari AA revealed likewise results as ours with r-value of – 0.08 and 0.012 respectively [13,15]. In brief AFI is neither useful indicator for assessing regional adiposity nor metabolic syndrome risk factors.
Depending on AFI, participants are divided into two groups; prominent visceral fat depot with AFI > 1 and prominent subcutaneous fat depot with AFI < 1. Forty participants in the current study showed prominent subcutaneous fat depots and 65 participants with prominent visceral fat depots. No significant correlation was obtained when these two groups are compared with their RBS values. According to study conducted by Hashimoto M et al., individuals with prominent visceral fat depots are at increased risk of cardiovascular events than the individuals with subcutaneous fat depots [24].
Current study and study performed by Shabestari AA et al., reveals equivalent results when waist circumference is used as measurement tool for regional adiposity [15]. When waist circumference was evaluated for metabolic risk factors the current study lags showing no correlation, while study performed by Shabestari AA et al., shows mild positive correlation. In the current study none of the anthropometric measurements showed any sort of positive correlation with RBS values [15]. However, some sonographic indices like IAF, subcutaneous fat thicknesses and preperitoneal fat thickness showed mild but positive correlation with metabolic risk factors.
Limitation
Considering BMI as indicator for regional adiposity; even though all obese/overweight by BMI standards may not have increased regional adiposity and likewise all normal/lean individuals may not have decreased regional adiposity. Secondly, we compared only one of the metabolic risk factors (random blood sugar levels) with sonographic and anthropometric indices, as only less than half of participants were with lipid profiles. Finally, most of the participants were on regular treatment with antihypertensives, oral hypoglycemic drugs and antistatins.
Conclusion
Sonography can be considered as one of the reliable, easily available, repeatable, reproducible, cost effective and non ionizing imaging modality for assessing the regional adiposity but not as better as waist or hip circumferences. Raised sonographic indices like IAF, SCF and PPF are dependable markers of metabolic syndrome.
Financial or Other Competing Interests
None.
References
- [1].Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1–253. [PubMed] [Google Scholar]
- [2]. Third National Family Health Survey. Mumbai: International Institute for Population Sciences. 2006. [cited 2006 September] Available from http://rchiips.org/nfhs/nfhs3.shtml. Accessed on 30th January 2015.
- [3].Vlachos IS, Hatziioannou A, Perelas A, Perrea ND. Sonographic assessment of regional adiposity. AJR. 2007;189:1545–53. doi: 10.2214/AJR.07.2366. [DOI] [PubMed] [Google Scholar]
- [4].Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–36. doi: 10.1161/ATVBAHA.107.151092. [DOI] [PubMed] [Google Scholar]
- [5].Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. Journal of Clinical Endocrinology and Metabolism. 2007;92(2):399–404. doi: 10.1210/jc.2006-0513. [DOI] [PubMed] [Google Scholar]
- [6].Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H, et al. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. Journal of the Cardiometabolic Syndrome. 2007;2(4):267–75. doi: 10.1111/j.1559-4564.2007.07392.x. [DOI] [PubMed] [Google Scholar]
- [7].Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pacific Journal of Clinical Nutrition. 2007;16(2):362–67. [PubMed] [Google Scholar]
- [8].Eapen D, Kalra GL, Merchant N, Arora A, Khan BV. Metabolic syndrome and cardiovascular disease in South Asians. Vascular Health and Risk Management. 2009;5:731–43. doi: 10.2147/vhrm.s5172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews. 2000;21(6):697–738. doi: 10.1210/edrv.21.6.0415. [DOI] [PubMed] [Google Scholar]
- [10].Alberti K, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine. 2006;23:469–80. doi: 10.1111/j.1464-5491.2006.01858.x. [DOI] [PubMed] [Google Scholar]
- [11].Stolk R, Wink O, Zelissen P, Meijer R, Gils A, Grobbee D. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. International Journal of Obesity. 2001;25:1346–51. doi: 10.1038/sj.ijo.0801734. [DOI] [PubMed] [Google Scholar]
- [12].Snehalatha C, Vishwanathan V, Ramchandran A. Cutoff values for normal anthro-pometric variables in Asian Indian adults. Diabetes Care. 2003;26:1380–84. doi: 10.2337/diacare.26.5.1380. [DOI] [PubMed] [Google Scholar]
- [13].Kim SK, Kim HJ, Hur KY, Choi SH, Ahn CW, Lim SK, et al. Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr. 2004;79:593–99. doi: 10.1093/ajcn/79.4.593. [DOI] [PubMed] [Google Scholar]
- [14].Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, et al. Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr. 2001;131(2):354–60. doi: 10.1093/jn/131.2.354S. [DOI] [PubMed] [Google Scholar]
- [15].Shabestari A A, Bahrami-Motlagh H, Hosseinpanah F, Heidari K. Abdominal fat sonographic measurement compared to anthropometric indices for predicting the presence of coronary artery disease. J Ultrasound Med. 2013;32(11):1957–65. doi: 10.7863/ultra.32.11.1957. [DOI] [PubMed] [Google Scholar]
- [16].Stolk RP, Meijer R, Mali WP, Grobbee DE, Van der Graaf Y. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. 2003;77:857–60. doi: 10.1093/ajcn/77.4.857. [DOI] [PubMed] [Google Scholar]
- [17].Pouliot MC, Desprӑs JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73(7):460–68. doi: 10.1016/0002-9149(94)90676-9. [DOI] [PubMed] [Google Scholar]
- [18].Roopakala MS, Suresh A, Ashtalakshmi Srinath, Ashok Giridhar, et al. Anthropometric measurements as predictors of intraabdominal fat thickness. Indian J Physiol Pharmacol. 2009;53(3):259–64. [PubMed] [Google Scholar]
- [19].Shojaei MH, Shirani S, Eshraghian MR, Soleymanzadeh M. Sonographic prediction of body fat volume (subcutaneous and visceral fat) in cardiovascular patients. J Teh Univ Heart Ctr. 2010;5(2):83–86. [PMC free article] [PubMed] [Google Scholar]
- [20].Tadokoro N, Murano S, Nishide T, Suzuki R, Watanabe S, Murayama H, et al. Preperitoneal fat thickness determined by ultrasonography is correlated with coronary stenosis and lipid disorders in non-obese male subjects. Int J Obes Relat Metab Disord. 2000;24:502–07. doi: 10.1038/sj.ijo.0801187. [DOI] [PubMed] [Google Scholar]
- [21].Shimizu H, Shimomura Y, Hayashi R, Ohtani K, Sato N, Futawatari T, et al. Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obes Relat Metab Disord. 1997;21:536–41. doi: 10.1038/sj.ijo.0800437. [DOI] [PubMed] [Google Scholar]
- [22].Seibert H, Pereira AM, Ajzen SA, Nogueira PC. Abdominal circumference measurement by ultrasound does not enhance estimating the association of visceral fat with cardiovascular risk. Nutrition. 2013;29(2):393–98. doi: 10.1016/j.nut.2012.06.014. [DOI] [PubMed] [Google Scholar]
- [23].Tayama K, Inukai T, Shimomura Y. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1999;43:49–58. doi: 10.1016/s0168-8227(98)00118-1. [DOI] [PubMed] [Google Scholar]
- [24].Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord. 1998;22:477–84. doi: 10.1038/sj.ijo.0800620. [DOI] [PubMed] [Google Scholar]